IFN? Production by Functionally Reprogrammed Tregs Promotes Antitumor Efficacy of OX40/CD137 Bispecific Agonist Therapy. (2024)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1158/2767-9764.crc-23-0500
PubMed Identifier: 38995700
Publication URI: http://europepmc.org/abstract/MED/38995700
Type: Journal Article/Review
Volume: 4
Parent Publication: Cancer research communications
Issue: 8
ISSN: 2767-9764